WeVote

Bill

Bill

HB 1237

Use of opioid settlement funds.

2026 Regular Session Introduced by Mark Genda

HB 1237 regulates how Indiana local governments must allocate opioid litigation settlement funds, specifying permitted uses and establishing oversight requirements.

First reading: referred to Committee on Local Government
0
WeVote Research Nonpartisan
Bill Summary · HB 1237

Legislative bill overview

HB 1237 establishes guidelines for how Indiana municipalities and counties must allocate opioid settlement funds received from litigation against pharmaceutical companies and distributors. The bill specifies permitted uses for these settlement proceeds and creates accountability measures for how local governments deploy this money.

Why is this important

Opioid settlements have generated billions in compensation funds nationwide, and how states direct this money significantly impacts community recovery efforts. Indiana's approach determines whether these funds address treatment, prevention, harm reduction, law enforcement, or infrastructure—directly affecting public health outcomes in communities affected by the opioid crisis.

Potential points of contention

  • Spending restrictions vs. flexibility: Rigid prescriptions on fund usage may prevent localities from addressing their specific opioid-related needs, while broad discretion could allow funds to be diverted to unrelated purposes
  • Administrative burden: Accountability and reporting requirements could create compliance costs that reduce funds actually available for treatment and prevention services
  • Equity concerns: The bill's allocation formula (if included) might benefit wealthier counties over rural or economically disadvantaged areas with severe opioid problems

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.